vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and OppFi Inc. (OPFI). Click either name above to swap in a different company.
OppFi Inc. is the larger business by last-quarter revenue ($85.6M vs $44.9M, roughly 1.9× AbCellera Biologics Inc.). OppFi Inc. runs the higher net margin — 19.7% vs -19.9%, a 39.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 5.9%). OppFi Inc. produced more free cash flow last quarter ($382.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 16.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
OppFi Inc. is a US-headquartered financial technology firm that provides responsible, accessible financial solutions including installment loans, credit-building tools and related support services to consumers underserved by traditional banking institutions, prioritizing fair terms to help users boost their long-term financial wellness.
ABCL vs OPFI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $85.6M |
| Net Profit | $-8.9M | $16.8M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 36.1% |
| Net Margin | -19.9% | 19.7% |
| Revenue YoY | 788.4% | 5.9% |
| Net Profit YoY | 73.9% | 400.3% |
| EPS (diluted) | $-0.03 | $1.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $85.6M | ||
| Q3 25 | $9.0M | $104.6M | ||
| Q2 25 | $17.1M | $100.2M | ||
| Q1 25 | $4.2M | $90.8M | ||
| Q4 24 | $5.0M | $80.8M | ||
| Q3 24 | $6.5M | $91.2M | ||
| Q2 24 | $7.3M | $86.3M | ||
| Q1 24 | $10.0M | $63.2M |
| Q4 25 | $-8.9M | $16.8M | ||
| Q3 25 | $-57.1M | $41.6M | ||
| Q2 25 | $-34.7M | $-20.8M | ||
| Q1 25 | $-45.6M | $-11.4M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $-51.1M | $4.3M | ||
| Q2 24 | $-36.9M | $3.1M | ||
| Q1 24 | $-40.6M | $5.5M |
| Q4 25 | -63.7% | 36.1% | ||
| Q3 25 | -851.8% | 46.3% | ||
| Q2 25 | -290.2% | 44.7% | ||
| Q1 25 | -1479.6% | 46.8% | ||
| Q4 24 | — | 30.5% | ||
| Q3 24 | -1439.4% | 38.5% | ||
| Q2 24 | -1276.2% | 34.2% | ||
| Q1 24 | -551.5% | 8.4% |
| Q4 25 | -19.9% | 19.7% | ||
| Q3 25 | -637.8% | 39.8% | ||
| Q2 25 | -203.3% | -20.7% | ||
| Q1 25 | -1077.2% | -12.5% | ||
| Q4 24 | — | -6.9% | ||
| Q3 24 | -785.4% | 4.7% | ||
| Q2 24 | -504.3% | 3.6% | ||
| Q1 24 | -408.0% | 8.8% |
| Q4 25 | $-0.03 | $1.48 | ||
| Q3 25 | $-0.19 | $0.77 | ||
| Q2 25 | $-0.12 | $-0.78 | ||
| Q1 25 | $-0.15 | $-0.48 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | $-0.17 | $0.21 | ||
| Q2 24 | $-0.13 | $0.16 | ||
| Q1 24 | $-0.14 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $49.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $58.5M |
| Total Assets | $1.4B | $754.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $49.5M | ||
| Q3 25 | $83.2M | $45.5M | ||
| Q2 25 | $92.4M | $45.2M | ||
| Q1 25 | $159.3M | $58.0M | ||
| Q4 24 | $156.3M | $61.3M | ||
| Q3 24 | $126.6M | $44.8M | ||
| Q2 24 | $148.3M | $46.6M | ||
| Q1 24 | $123.6M | $47.2M |
| Q4 25 | $966.9M | $58.5M | ||
| Q3 25 | $964.0M | $49.4M | ||
| Q2 25 | $1.0B | $13.4M | ||
| Q1 25 | $1.0B | $22.6M | ||
| Q4 24 | $1.1B | $32.8M | ||
| Q3 24 | $1.1B | $34.9M | ||
| Q2 24 | $1.1B | $18.6M | ||
| Q1 24 | $1.1B | $18.2M |
| Q4 25 | $1.4B | $754.1M | ||
| Q3 25 | $1.4B | $720.6M | ||
| Q2 25 | $1.4B | $673.4M | ||
| Q1 25 | $1.3B | $640.1M | ||
| Q4 24 | $1.4B | $641.2M | ||
| Q3 24 | $1.4B | $619.3M | ||
| Q2 24 | $1.4B | $573.1M | ||
| Q1 24 | $1.5B | $563.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $401.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $382.2M |
| FCF MarginFCF / Revenue | -99.4% | 446.6% |
| Capex IntensityCapex / Revenue | 21.9% | 22.3% |
| Cash ConversionOCF / Net Profit | — | 23.82× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $652.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $401.3M | ||
| Q3 25 | $-52.6M | $105.1M | ||
| Q2 25 | $-32.4M | $95.6M | ||
| Q1 25 | $-11.6M | $83.7M | ||
| Q4 24 | $-108.6M | $323.8M | ||
| Q3 24 | $-28.9M | $77.6M | ||
| Q2 24 | $-30.0M | $77.3M | ||
| Q1 24 | $-41.7M | $74.4M |
| Q4 25 | $-44.6M | $382.2M | ||
| Q3 25 | $-61.5M | $99.9M | ||
| Q2 25 | $-45.8M | $91.0M | ||
| Q1 25 | $-22.2M | $79.3M | ||
| Q4 24 | $-187.0M | $310.8M | ||
| Q3 24 | $-47.4M | $73.7M | ||
| Q2 24 | $-50.1M | $74.7M | ||
| Q1 24 | $-65.8M | $72.3M |
| Q4 25 | -99.4% | 446.6% | ||
| Q3 25 | -687.0% | 95.6% | ||
| Q2 25 | -267.9% | 90.8% | ||
| Q1 25 | -524.0% | 87.4% | ||
| Q4 24 | -3702.8% | 384.6% | ||
| Q3 24 | -728.4% | 80.8% | ||
| Q2 24 | -683.8% | 86.6% | ||
| Q1 24 | -661.5% | 114.4% |
| Q4 25 | 21.9% | 22.3% | ||
| Q3 25 | 99.7% | 5.0% | ||
| Q2 25 | 78.2% | 4.6% | ||
| Q1 25 | 251.1% | 4.8% | ||
| Q4 24 | 1552.7% | 16.1% | ||
| Q3 24 | 284.6% | 4.3% | ||
| Q2 24 | 274.6% | 3.0% | ||
| Q1 24 | 242.5% | 3.4% |
| Q4 25 | — | 23.82× | ||
| Q3 25 | — | 2.52× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.19× | ||
| Q2 24 | — | 25.21× | ||
| Q1 24 | — | 13.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
